GLP-1 Medications for Osteoarthritis
Osteoarthritis is the most common form of arthritis caused by wear and tear on joint cartilage, significantly worsened by excess body weight. Every pound of weight lost reduces 4 pounds of pressure on the knee joint. GLP-1 weight loss dramatically reduces osteoarthritis pain and improves mobility. Osteoarthritis affects over 32.5 million adults in the United States, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
over 32.5 million adults in the United States
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Osteoarthritis
Every pound of weight lost reduces 4 pounds of pressure on the knee joint. GLP-1 weight loss dramatically reduces osteoarthritis pain and improves mobility. For patients with osteoarthritis, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Osteoarthritis
Based on clinical evidence, the following GLP-1 medications are recommended for patients with osteoarthritis:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Osteoarthritis
Osteoarthritis & GLP-1 FAQ
Can GLP-1 medications help with osteoarthritis?
Yes. Every pound of weight lost reduces 4 pounds of pressure on the knee joint. GLP-1 weight loss dramatically reduces osteoarthritis pain and improves mobility. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with osteoarthritis.
Which GLP-1 medication is best for osteoarthritis?
Semaglutide is often the first-line recommendation for osteoarthritis due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have osteoarthritis?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of osteoarthritis and other health factors.
How prevalent is osteoarthritis?
Osteoarthritis affects over 32.5 million adults in the United States. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.